55 related articles for article (PubMed ID: 11236102)
1. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?
Lange CG; Woolley IJ; Brodt RH
Drugs; 2004; 64(7):679-92. PubMed ID: 15025543
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis carinii pneumonia after cessation of secondary prophylaxis in a patient on highly active antiretroviral therapy with a CD4 cell count greater than 200/mm3.
Lim L ; Street AC; Lewin SR
AIDS; 2001 Sep; 15(14):1912-3. PubMed ID: 11579267
[No Abstract] [Full Text] [Related]
4. Pneumocystis carinii pneumonia following discontinuation of primary prophylaxis despite highly active antiretroviral therapy.
Mammen-Tobin A; Monteiro EF
Int J STD AIDS; 2000 Jan; 11(1):64-5. PubMed ID: 10667904
[No Abstract] [Full Text] [Related]
5. Discontinuation of secondary prophylaxis for Pneumocystis pneumonia in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.
Esposito S; Bojanin J; Porta A; Cesati L; Gualtieri L; Principi N
Pediatr Infect Dis J; 2005 Dec; 24(12):1117-20. PubMed ID: 16371882
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
Ledergerber B; Mocroft A; Reiss P; Furrer H; Kirk O; Bickel M; Uberti-Foppa C; Pradier C; D'Arminio Monforte A; Schneider MM; Lundgren JD;
N Engl J Med; 2001 Jan; 344(3):168-74. PubMed ID: 11188837
[TBL] [Abstract][Full Text] [Related]
7. A case of pneumocystis pneumonia after cessation of secondary prophylaxis.
Quah SP; McBride M
Int J STD AIDS; 2001 Feb; 12(2):126-7. PubMed ID: 11236102
[TBL] [Abstract][Full Text] [Related]
8. Primary and secondary prophylaxis for Pneumocystis carinii related complications in HIV patients.
Held M; Goebel FD
Eur Respir J; 1996 May; 9(5):868-71. PubMed ID: 8793444
[No Abstract] [Full Text] [Related]
9. Quality standard for the prophylaxis of Pneumocystis carinii pneumonia in infants and children born to women infected with human immunodeficiency virus.
Wilfert CM; Masur H; Gross PA; Kaplan JE; Holmes KK; Phair JP; Simonds RJ
Clin Infect Dis; 1995 Aug; 21 Suppl 1():S132-3. PubMed ID: 8547506
[No Abstract] [Full Text] [Related]
10. Quality standard for the prophylaxis of Pneumocystis carinii pneumonia in adults and adolescents infected with human immunodeficiency virus.
Phair JP; Masur H; Gross PA; Holmes KK; Kaplan JE
Clin Infect Dis; 1995 Aug; 21 Suppl 1():S128-9. PubMed ID: 8547504
[No Abstract] [Full Text] [Related]
11. Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing?
Miller RF
Thorax; 2000 Aug; 55 Suppl 1(Suppl 1):S15-22. PubMed ID: 10943633
[No Abstract] [Full Text] [Related]
12. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.
Huang YS; Yang JJ; Lee NY; Chen GJ; Ko WC; Sun HY; Hung CC
Expert Rev Anti Infect Ther; 2017 Sep; 15(9):873-892. PubMed ID: 28782390
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
